Samsung BioLogics says report on Biogen deal talks untrue
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/27/2026
- Wall Street stocks end tad lower after hot inflation data ahead of Nvidia earnings
- Nvidia forecasts 70% sales growth next year, signals AI spending boom has years left to run
- Oil settles down after choppy session as investors weigh Hormuz talks
- Meta to pay up to $16.68 billion in mass social media settlement
- Anthropic agrees to $45bn cloud computing deal with Nscale - report
- Nutanix (NTNX) Tops Q4 EPS by 11c, Beats in Revenue; Offers Q1 Revenue Guidance
- Boston Scientific discloses cybersecurity incident causing global disruption
- Crude Inventory Rose 0.1 Million Barrels Last Week - EIA
- FDA approves Revolution Medicines pancreatic cancer drug Rasonque
- NVIDIA (NVDA) Tops Q2 EPS by 14c, Offers Guidance
Samsung BioLogics Said Biogen (BIIB) Buyout Rumor 'Untrue'
December 29, 2021 11:59 PM ESTSamsung BioLogics said a report that Samsung Group was in talks to acquire Biogen Inc. (NASDAQ: BIIB) is not true.
... MoreBiogen (BIIB) Could be Valued at $42B Cash in Samsung Deal, Here Are Key Questions According to Truist Securities
December 29, 2021 5:01 PM ESTTruist analyst Robyn Karnauskas reiterates a "Buy" rating and $502 price target on shares of Biogen (NASDAQ: BIIB), following rumors of potential takeover of the company by Samsung Group.
The analyst quotes:
"While there is no price set yet, Biogen approached Samsung to... More